Acta Neuropharmacologica

Previous Articles    

Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease

YANG-Lin,AI-Jing   

  1. Department of Pharmacology,Harbin Medical University,Harbin,150086,China
  • Online:2019-10-26 Published:2020-03-03
  • Contact: 艾静,女,博士,教授,博士生导师;研究方向:神经药理学;Tel:+86-0451-86671354,E-mail:azhrbmu@126.com
  • About author:杨琳,女,硕士研究生;研究方向:神经药理学;E-mail:linyang52@163.com
  • Supported by:
    国家自然科学基金资助项目(No.81671052、No.81870849、No.81471115),黑龙江省自然基金重点项目(No.ZD2018004)

Abstract:

Epidemiological studies have shown that the risk of Alzheimer’s disease (AD)in postmenopausal women is much higher than that in men. Numerous clinical trials have indicated that decreased level of brain-derived estrogen in women is related to the risk of AD. This review focuses on the synthesis,metabolism and action mechanisms of estrogen(especially brain-derived estrogen),the role of brain estrogen receptors(ERs),brain-derived estrogen in the regulation of cognitive function and brain-derived estrogen dysfunction in the progression of AD.

Key words: Alzheimer’s disease, brain-derived estrogen, estrogen receptors

CLC Number: